author

 
 

Meta

Deena Beasley
It is still unclear whether BA.2.86 will be able to out-compete other strains of the virus that causes COVID-19, or have any advantage in escaping immune responses from prior infection or vaccination.
WORLD / Science & Health / EXPLAINER
Aug 21, 2023
What you need to know about BA.2.86, the new COVID variant
Scientists are keeping an eye on the new lineage because it has 36 mutations that distinguish it from the currently dominant XBB.1.5 variant.
Elizabeth Kutschke at the park with her son Ben, who was diagnosed with spinal muscular atrophy
WORLD / Science & Health
Aug 15, 2023
When a $2 million gene therapy is not enough
Ben is one of a growing number of patients with spinal muscular atrophy whose doctors are turning to additional drugs in addition to gene therapy.
Japan Times
WORLD / Science & Health
May 5, 2023
Experimental Alzheimer's drug slowed disease by 35% in trial, Eli Lilly reports
The results provide what experts say is the strongest evidence yet that removing sticky amyloid plaques from the brain benefits patients with the fatal disease.
Japan Times
ASIA PACIFIC / Science & Health
Dec 17, 2022
COVID projections predict over 1 million deaths in China through 2023
As China begins to experience a spike in infections, fears are growing that coronavirus cases could sweep across its 1.4 billion population during the Lunar New Year holiday.
Japan Times
WORLD / Science & Health
Feb 1, 2022
How does Merck's COVID-19 pill compare to Pfizer's?
Pfizer said final trial results showed that its treatment reduced the chance of hospitalization or death by 89%, while Merck said their pill reduced those chances by 30%.
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
Japan Times
WORLD / Science & Health
Jun 28, 2020
As world passes 10 million COVID-19 cases, doctors see hope in new treatments and lessons learned
Nearly 30 doctors around the world, from New Orleans to London to Dubai, said in interviews that they feel more prepared should cases surge again in the fall.

Longform

The National Museum of Emerging Science and Innovation in Tokyo is a popular place to foster curiosity in the natural sciences.
Can Japan's scientific community rebound from a Nobel nosedive?